 |
| 830 Winter Street, Waltham, MA |
BOSTON, MA – Holliday
Fenoglio Fowler, L.P. (HFF) announced it has secured $74.24 million in first
mortgage financing for 830 Winter
Street, a 182,104-square-foot, Class A lab/biotech building in Waltham,
Massachusetts, a western suburb of Boston.
 |
| Greg LaBine |
HFF worked on behalf of
the borrower, a joint venture between King Street Properties and an affiliate
of Carlyle Realty Partners VII, LP, in arranging the floating-rate loan with
Wells Fargo.
830 Winter Street is
situated off Route 95/Route 128 at exit 27 in Waltham about 12 miles west of
Boston. This location places the asset
between Route 2 to the north and Interstate 90/the Massachusetts Turnpike to the
south and in close proximity to the new 1265 Main Street mixed-use
development.
Completed in 2001 as the
flagship headquarters for Praecis Pharmaceuticals, the property remains fully
leased today to ImmunoGen, GlaxoSmithKline and Histogenics Corporation.
The HFF debt placement
team representing the borrower was led by managing director Greg LaBine.
“This is one of the
premier laboratory facilities in the Boston suburbs,” said LaBine. “As is the case with many acquisitions in the
current market environment, the financing had to be obtained quickly to hit the
tight closing time frame. HFF, along
with a tremendous effort by the Wells Fargo team, was able to close the deal
within 54 days of our initial engagement.”
For a complete copy of the company’s news
release, please contact:
Kristen M. Murphy
Associate Director
HFF | One Post Office
Square, Suite 3500 | Boston, MA 02109
Main: 617-338-0990 |
Direct: 617-848-1572 | Cell: 617-543-4873 | www.hfflp.com
Web: www.carlyle.com
Tweets: www.twitter.com/onecarlyle
No comments:
Post a Comment